Alcoholism & Drug Abuse Weekly
Comments on methadone take‐home timing study
By Alison Knopf.
Abstract
Last week we wrote about a study and accompanying commentary published in JAMA Internal Medicine that found methadone take‐homes can be given too early — namely, in the first four weeks of treatment (see https://onlinelibrary.wiley.com/doi/10.1002/adaw.35049 ). The study, “Timing of Initiation of Methadone Take‐Home Dosing,” by Belal Hossain, and the commentary on it, “Initiation of Take‐Home Medication Dosing and Methadone Maintenance Treatment Effectiveness” by Paul J. Joudrey, M.D., supported methadone take‐homes in general. Joudrey, who wrote the commentary, has been a particular advocate of “liberating methadone” from U.S. opioid treatment programs (OTPs), allowing physicians to prescribe and pharmacies to dispense it. The study itself was conducted in Canada, where there are no OTPs and methadone is dispensed by pharmacies, without the wraparound services of OTPs.
Keywords
- Opioid Use Disorder Treatment
- Methadone
- Dosing
- Methadone maintenance
- Pharmacy
- Opioid
- Opioid use disorder
- Open access
Source
Published in Alcoholism & Drug Abuse Weekly. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.